natgillin/translations-raw huggingface dataset:
Dicuno 50 mg filmsko obložene tablete 
Dicuno 50 mg filmsko obložene tablete filmom obložena tableta
Diclofenac sodium DOLO-VOLTAREN 50 mg comprimidos dispersables 
DOLO-VOLTAREN 50 mg comprimidos dispersables tableta za oralnu suspenziju
Diclofenac sodium Diclofenacnatrium 50 mg, maagsapresistente tabletten 
Diclofenacnatrium 50 mg, maagsapresistente tabletten
Diclofenac sodium Diclofenacnatrium Actavis 25 mg, maagsapresistente tabletten 
Diclofenacnatrium Actavis 25 mg, maagsapresistente tabletten
Hartkapsel 
KAPPADI
Diclofenac sodium Sandoz Ltd Rhumalgan CR100 
Sandoz Ltd Rhumalgan CR100 Modified Release Tablet 100mg
Dicuno 25 mg filmsko obložene tablete 
Dicuno 25 mg filmsko obložene tablete filmom obložena tableta
Diclofenac sodium DICLO-DENK 100mg RETARD 
DICLO-DENK 100mg RETARD
Modified-Release Capsule, Hard 
Modifenac kapsula s prilagođenim oslobađanjem, tvrda
Diclofenac sodium VOLTAREN RETARD 100 mg comprimidos de liberación modificada 
VOLTAREN RETARD 100 mg comprimidos de liberación modificada
Diclofenac sodium TAKS INJECTION 75MG/3ML 
TAKS INJECTION 75MG/3ML
Diclofenac sodium Dicloberl 50 mg Tabletten 
Dicloberl 50 mg Tabletten
Diclofenacum natricum Diclac ID 75 mg modified release tablets 
Diclac ID 75 mg modified release tablets tableta s prilagođenim oslobađanjem
Diclofenac sodium DICLOFENAC SANDOZ 50 MG 
DICLOFENAC SANDOZ 50 MG
Diclofenac sodium DICLOFENACO RETARD STADA 100 mg comprimidos 
DICLOFENACO RETARD STADA 100 mg comprimidos EFG
Diclofenac sodium Diklofenak Orifarm 25mg 
Diklofenak Orifarm 25 mg
Diclofenac sodium Diclofenac Na retard 75 PCH, tabletten met gereguleerde afgifte 75 mg 
Diclofenacnatrium Disphar Retard 75, tabletten met gereguleerde afgifte 75 mg tableta s prilagođenim oslobađanjem
Gastroresistant tablet 
želučanootporna obložena tableta
Diclofenac sodium Rewodina dual 75 Kaps 
Rewodina dual 75 Kaps kapsula
Diclofenac potassium Otriflu, omhulde tabletten 12,5 mg 
Otriflu, omhulde tabletten 12,5 mg
Diclofenac sodium Deflamat DRS 75 mg - Kapseln 
Deflamat DRS 75 mg - Kapseln kapsula, tvrda
13 24941 Flensburg Germany 
Juta Pharma GmbH Gutenbergstr. 13 24941 Flensburg Germany
Diclofenac sodium Diclofenacnatrium 25 mg, maagsapresistente tabletten 
Diclofenacnatrium 25 mg, maagsapresistente tabletten
Diclofenac sodium Diclofenac STADA 50mg magensaftresistente 
Diclofenac STADA 50mg magensaftresistente Tabletten
Italy ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany 
Italija ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Diclofenac potassium Voltaren K 12,5 mg, filmomhulde tabletten 
Voltaren K 12,5 mg, filmomhulde tabletten
Diclofenac sodium Diclofenac STADA 25mg magensaftresistente 
Diclofenac STADA 25mg magensaftresistente Tabletten
Diclofenac sodium Diclofenacnatrium 25 PCH, zetpillen 25 mg 
Diclofenacnatrium Disphar 25, zetpillen 25 mg čepić rektalno
Solution for injection or concentrate for solution for infusion 
Difene ampoules 75 mg/3 ml Solution for Injection or Concentrate for Solution for Infusion
DICLAC ID 150 MG 150mg 
Diclac 150 mg ID 150 mg tableta s produljenim oslobađanjem
Diclofenac sodium Diklofenak Sandoz 50mg 
Diklofenak Sandoz 50 mg
Estonia ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany 
Estonija ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Diclofenac sodium Rheumatac Retard Tablets 75mg 
Dexcel-Pharma Diclofenac Sodium Tablets 75mg
Norway ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany 
Norveška ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Diclofenac sodium VOLTARENE 100 mg, suppositoire 
VOLTARENE 100 mg, suppositoire
100 mg comprimidos de liberación modificada EFG 
DI-RETARD 100 mg comprimidos de liberación modificada
Lithuania ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany 
Litva ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Diclofenac sodium Dolpasse 75 mgInfusionslösung 
Dolpasse 75 mgInfusionslösung
Latvia ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany 
Latvija ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Poland ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany 
Poljska ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Diclofenac sodium Diclac 100 mg Suppositories 
Diclac 100 mg Suppositories
Diclofenac sodium Diclofenac "Genericon" 50 mgFilmtabletten 
Diclofenac "Genericon" 50 mgFilmtabletten filmom obložena tableta
Diclofenacum kalium Voltaren Rapid 
Voltaren Rapid obložena tableta
Controlled release tablet 
tableta s produljenim oslobađanjem
12,5mg Film-coated tablet Oral use 
Otriflu 12.5mg Filmcoated Tablets
Diclofenac sodium Diclofenac Sandoz 50 mg magensaftresistente 
Diclofenac Sandoz 50 mg magensaftresistente Tabletten
Diclofenac sodium VOLTAREN 100 mg supositorios 
VOLTAREN 100 mg supositorios
Diclofenac sodium Voltarol Tablets 25mg 
Voltarol Tablets 25mg
Diclofenac sodium Effekton 25 mg magensaftresistente 
Diclofenacratiopharm 25 mg magensaftresistente Tabletten
Diclofenac sodium Diclac-100 Zäpfchen 100mg suppository 
Diclac-100 Zäpfchen 100 mg čepić rektalno
Leicester, LE3 0PA 
Florapark 4
Diclofenac sodium Diclofenacnatrium 50 PCH, zetpillen 50 mg 
Diclofenacnatrium 100 PCH, zetpillen 100 mg
Diclofenac sodium Dexcel-Pharma Diclofenac Sodium 
Dexcel-Pharma Diclofenac Sodium Tablets 25mg
Diclofenac sodium Diclofenbeta 50 50mg 
Diclofenbeta 50 50 mg
Diclofenacum natricum Diclomelan 50 mg gastro-resistant tablets 
Diclomelan 50 mg gastro-resistant tablets
Prolonged-release tablet 
Retardtabletten tableta s produljenim oslobađanjem
Diclofenac sodium Chatfield Pharms Diclofenac Sodium 
Chatfield Pharms Diclofenac Sodium Tablets 25mg
Diclofenac sodium Voltarol Injection 75mg/3ml 
VOLTAREN INJECTION 75MG/3ML
Release Tablet 75mg 
VOLTAREN SR SUSTAINED RELEASE TABLET 75MG
Diclofenacum natricum Naklofen Duo 
Naklofen DUO
Diclofenac sodium Diklofenak Orifarm 50mg 
Diklofenak Orifarm 50 mg
Diclofenac potassium Diclobene rapid 50 mg Filmtabletten 
Diclomex Rapid 50 mg filmom obložena tableta
Diclofenac sodium Olfen-100 Rectocaps 100mg 
Olfen-100 Rectocaps 100 mg čepić rektalno
Diclofenac sodium Flamatak MR Tablets 75mg 
Mercury Pharms Diclofenac Sodium Tablets 75mg tableta
Diclofenacum natricum Profenac 75 mg/3 ml solution for injection 
Profenac 75 mg/3 ml solution for injection
VOLTAREN® 50mg 
VOLTAREN SUPPOSITORY 50MG
Diclofenac sodium NERITAN GASTRO RESISTANT TABLET 
DiclofenacKalium ratiopharm filmom obložena tableta
Diclofenac sodium Diclofenacnatrium Apotex 25 mg, zetpillen 
Diclofenacnatrium Apotex 25 mg, zetpillen čepić rektalno
Diclofenac sodium Diclo KSK 50 mg 50mg 
Diclo KSK 50 mg 50 mg
Diclofenac sodium DICLOFENAC TEVA 25 mg, comprimé enrobé gastrorésistant 
Diclofenacnatrium 25 mg Teva, zetpilen čepić rektalno
Diclofenac sodium Olfen-75 SR Depotabs 
Olfen-75 SR Depotabs tableta s prilagođenim oslobađanjem
Diclofenac sodium Diclo-saar 75mg SF Injektionslösung 
Diclo-saar 75mg SF Injektionslösung otopina za injekciju u mišić
Diclofenac sodium VOLTARENE 25 mg, comprimé gastrorésistant 
VOLTARENE 25 mg, comprimé gastrorésistant
Film-coated prolonged release tablet 
Voltarol Retard 100 mg Film-coated Prolonged Release Tablets
Diclofenac sodium Tratul retard 100 mg - Filmtabletten 
Tratul retard 100 mg - Filmtabletten
Diclofenac colestyramin Voltaren Resinat 
Germany diklofenak kolestiramin Voltaren resinat
Diclofenac potassium Voltaren rapid 50 mg - Dragees 
Voltaren rapid 50 mg - Dragees obložena tableta
Diclofenac sodium DICLOFENAC TEVA 50 MG 
DICLOFENAC TEVA 50 MG
Diclofenac sodium Arthrotec 50 modified release tablets 
Sandoz Ltd Diclovol SR Modified Release Tablet 75 mg tableta s prilagođenim oslobađanjem
Diclofenac sodium Deflamat 100 mgSuppositorien 
Deflamat 100 mgSuppositorien
Diclofenac sodium DOLOTREN 50 mg comprimidos gastrorresistentes 
DOLOTREN 50 mg comprimidos gastrorresistentes
Diclofenac sodium Diclofenacnatrium Disphar Retard 100, tabletten met gereguleerde afgifte 
Diclofenacnatrium Disphar Retard 100, tabletten met gereguleerde afgifte 100 mg
Diclofenac potassium Voltaren Dolo 12,5 mg 
Voltaren Dolo 12,5 mg
Diclofenac sodium DICLAC 50 HEXAL GASTRO-RESISTANT 
DICLAC 50 HEXAL GASTRO-RESISTANT TABLET 50MG
Diclofenac sodium ALMIRAL GASTRORESISTANT TABLET 
Diclofenac Rapid Orifarm filmom obložena tableta
Diclofenac sodium Diklofenak Mylan 100mg 
DICLOFENAC RETARD MYLAN 100MG
Oral drops, solution 
oralne kapi, otopina kroz usta
Diclofenac sodium Diclofenac MEDA 25 mg Brausetabletten 
Diclofenac MEDA 25 mg Brausetabletten šumeća tableta
Diclofenac sodium ARESTON TABLET 50MG 
Lagap Pharms Diclofenac Tablets 50mg
Prolonged-release film-coated tablet 
Diklotab filmom obložena tableta
Diclofenac sodium Diclofenac MEDA 50 mg Brausetabletten 
Diclofenac MEDA 50 mg Brausetabletten šumeća tableta
Diclofenacum natricum Naklofen 75 mg/3 ml solution for injection 
Naklofen 75 mg/3 ml solution for injection
Tratul 50 mgKapseln 
TRATUL 50 mg želučanootporna kapsula, meka
Diclofenac sodium Diclac 75 mg/3 ml Injektionslösung solution for injection 
Diclofenac STADA N 75 mg/3 ml Injektionslösung
Diclofenac Orphenadrine 
Austria diklofenak orfenadrin
This authorisation was based on the authorisation granted to Taxotere in 1995 (‘informed consent'). 
Odobrenje se temeljilo na odobrenju koje je 1995. izdano za lijek Taxotere („informirani pristanak”).
1 Previously known as Docetaxel Winthrop. 
1 Prethodno poznat pod nazivom Docetaxel Winthrop.
• breast cancer. 
• raka dojke.
Further information on Docetaxel Zentiva can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/docetaxel-zentiva. 
Više informacija o lijeku Docetaxel Zentiva dostupno je na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/docetaxel-zentiva.
Docetaxel Zentiva1 (docetaxel) 
Docetaxel Zentiva1 (docetaksel)
• prostate cancer, when the cancer has spread to other parts of the body (metastatic). 
• raka prostate, kada se rak proširio na druge dijelove tijela (metastatski).
• head and neck cancer in patients whose cancer is locally advanced (a cancer that has grown but has not spread). 
• raka glave i vrata u bolesnika u kojih je rak lokalno uznapredovao (rak koji je narastao, ali se nije proširio).
Docetaxel Zentiva is given as a 1-hour infusion (drip) into a vein every 3 weeks. 
Docetaxel Zentiva primjenjuje se kao intravenska infuzija (ukapavanje) u trajanju od jednog sata svaka tri tjedna.
It can also be used with androgen-deprivation therapy when hormonal treatment still works (hormone-sensitive prostate cancer); 
Može se primjenjivati i s terapijom deprivacije androgena kada hormonska terapija još uvijek djeluje (rak prostate osjetljiv na hormone);
Docetaxel Zentiva received a marketing authorisation valid throughout the EU on 20 April 2007. 
Lijek Docetaxel Zentiva dobio je odobrenje za stavljanje u promet koje je na snazi u EU-u od 20. travnja 2007.
The most common side effects with Docetaxel Zentiva (which may affect more than 1 in 10 people) are neutropenia (low levels of neutrophils, white blood cells that fight infection), anaemia (low red blood cell counts), stomatitis (inflammation of the lining of the mouth), diarrhoea, nausea (feeling sick), vomiting, alopecia (hair loss) and asthenia (weakness). 
Najčešće nuspojave lijeka Docetaxel Zentiva (koje se mogu javiti u više od 1 na 10 osoba) jesu neutropenija (niske razine neutrofila, bijelih krvnih stanica koje se bore protiv infekcije), anemija (nizak broj crvenih krvnih zrnaca), stomatitis (upala sluznice usne šupljine), proljev, mučnina (slabost), povraćanje, alopecija (gubitak kose) i astenija (slabost).
With the skeleton still in place, the cells cannot divide and they eventually die. 
Sve dok postoji kostur, stanice se ne mogu dijeliti i naposljetku odumiru.
Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Docetaxel Zentiva have been included in the summary of product characteristics and the package leaflet. 
Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Docetaxel Zentiva nalaze se u sažetku opisa svojstava i u uputi o lijeku.
Docetaxel Zentiva must not be used in patients who have a neutrophil count of less than 1,500 cells/mm3 or who have severe problems with their liver. 
Docetaxel Zentiva ne smije se primjenjivati u bolesnika kod kojih je broj neutrofila manji od 1 500 stanica/mm3 ili u bolesnika koji imaju ozbiljne probleme s jetrom.
The dose, duration of treatment and the medicines it is used with depend on the type of cancer being treated and the patient's weight and height. 
Doza, trajanje terapije i lijekovi s kojima se primjenjuje ovise o vrsti raka koji se liječi te o bolesnikovoj tjelesnoj težini i visini.
An anti-inflammatory medicine such as dexamethasone should also be given to the patient, starting on the day before the Docetaxel Zentiva infusion. 
Bolesnicima bi trebalo dati i protuupalni lijek kao što je deksametazon, čija bi primjena trebala početi dan prije infuzije lijekom Docetaxel Zentiva.
In most of these studies, Docetaxel Zentiva was combined with other anticancer treatments and compared either with the medicines it is used in combination with or with a combination of different treatments. 
U većini ovih ispitivanja lijek Docetaxel Zentiva primjenjivao se u kombinaciji s drugim lijekovima protiv raka te se uspoređivao s lijekovima s kojima se uzimao u kombinaciji ili s kombinacijom različitih terapija.
Docetaxel Zentiva has been studied in over 4,000 breast-cancer patients, around 2,000 non-small-celllung-cancer patients, around 2,700 prostate-cancer patients, 457 gastric-adenocarcinoma patients and 897 head- and neck-cancer patients. 
Lijek Docetaxel Zentiva ispitivan je u više od 4 000 osoba oboljelih od raka dojke, otprilike 2 000 osoba oboljelih od raka pluća nemalih stanica, otprilike 2 700 osoba oboljelih od raka prostate, 457 osoba oboljelih od adenokarcinoma želuca i 897 osoba oboljelih od raka glave i vrata.
Side effects reported with Docetaxel Zentiva are carefully evaluated and any necessary action taken to protect patients. 
Nuspojave prijavljene za lijek Docetaxel Zentiva pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
The dose of Docetaxel Zentiva may need to be reduced, or treatment interrupted or discontinued, if the patient develops certain side effects. 
Dozu lijeka Docetaxel Zentiva možda će biti potrebno smanjiti ili liječenje privremeno ili trajno prekinuti ako se kod bolesnika pojave određene nuspojave.
Adding Docetaxel Zentiva to other cancer treatments increased the number of patients whose cancer responded to treatment, how long the patients lived without their disease getting worse and how long the patients survived, in all five types of cancer. 
Dodavanjem lijeka Docetaxel Zentiva drugim terapijama za liječenje raka povećan je broj bolesnika čiji je rak odgovorio na terapiju, produljen život bolesnicima bez pogoršanja bolesti i produljeno preživljenje bolesnika, i to kod svih pet vrsta raka.
What measures are being taken to ensure the safe and effective use if Docetaxel Zentiva? 
Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Docetaxel Zentiva?
Docetaxel blocks the ability of cells to break down the internal ‘skeleton' that allows them to divide. 
Docetaksel djeluje inhibirajući sposobnost stanica raka da razgrade vlastiti unutarnji „kostur”, što im omogućuje diobu.
Because docetaxel works on dividing cells, it also affects non-cancer cells such as blood cells, which can cause side effects. 
S obzirom na to da docetaksel djeluje na diobu stanica, on djeluje i na stanice koje nisu stanice raka, poput krvnih stanica, što može uzrokovati nuspojave.
What is Docetaxel Zentiva and what is it used for? 
Što je Docetaxel Zentiva i za što se koristi?
It can also be used with other cancer medicines (doxorubicin, cyclophosphamide, trastuzumab or capecitabine) in patients who have not yet received any treatment for their cancer or after other treatments have failed, depending on the type and stage of the breast cancer being treated; 
Može se primjenjivati i u kombinaciji s drugim lijekovima protiv raka (doksorubicin, ciklofosfamid, trastuzumab ili kapecitabin) u bolesnika koji još nisu primili nikakvu terapiju za liječenje raka ili nakon što druge terapije nisu bile uspješne, ovisno o vrsti i stadiju raka dojke koji se liječi;
The European Medicines Agency decided that Docetaxel Zentiva's benefits are greater than its risks and it can be authorised for use in the EU. 
Europska agencija za lijekove zaključila je da koristi od lijeka Docetaxel Zentiva nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u EU-u.
As for all medicines, data on the use of Docetaxel Zentiva are continuously monitored. 
Kao i za sve lijekove, podatci o primjeni lijeka Docetaxel Zentiva kontinuirano se prate.
These side effects may be more severe when Docetaxel Zentiva is used with other cancer medicines. 
Te nuspojave mogu biti teže ako se Docetaxel Zentiva primjenjuje s drugim lijekovima protiv raka.
Docetaxel Zentiva can be used on its own after other treatments have failed. 
Docetaxel Zentiva može se primjenjivati kao monoterapija nakon što druge terapije nisu bile uspješne.
Docetaxel Zentiva is used with prednisone or prednisolone (anti-inflammatory medicines) when the cancer cannot be treated by greatly reducing the body's production of testosterone (castration-resistant prostate cancer). 
Lijek Docetaxel Zentiva primjenjuje se u kombinaciji s prednizonom ili prednizolonom (protuupalnim lijekovima) u slučajevima kada se rak ne može liječiti znatnim smanjenjem proizvodnje testosterona u tijelu (rak prostate otporan na kastraciju).
Docetaxel Zentiva is a cancer medicine used to treat the following types of cancer: 
Docetaxel Zentiva lijek je protiv raka koji se koristi za liječenje sljedećih vrsta raka:
For more information about using Docetaxel Zentiva, see the package leaflet or contact your doctor or pharmacist. 
Za više informacija o primjeni lijeka Docetaxel Zentiva pročitajte uputu o lijeku odnosno obratite se liječniku ili ljekarniku.
Other information about Docetaxel Zentiva 
Ostale informacije o lijeku Docetaxel Zentiva
• gastric adenocarcinoma (a type of stomach cancer) in patients who have not yet received any treatment for their cancer. 
• adenokarcinoma želuca (vrste raka želuca) u bolesnika koji još nisu primili nikakvu terapiju za liječenje raka od kojeg boluju.
Docetaxel Zentiva is used with cisplatin and fluorouracil (other cancer medicines); 
Lijek Docetaxel Zentiva primjenjuje se u kombinaciji s cisplatinom i fluorouracilom (drugim lijekovima protiv raka);
An overview of Docetaxel Zentiva and why it is authorised in the EU 
Pregled informacija o lijeku Docetaxel Zentiva i zašto je odobren u EU-u
Docetaxel Zentiva can only be obtained with a prescription and is used in units specialising in giving chemotherapy (medicines to treat cancer) under the supervision of a doctor who is qualified in the use of chemotherapy. 
Lijek Docetaxel Zentiva izdaje se samo na recept i primjenjuje se na odjelima specijaliziranima za kemoterapiju (lijekove za liječenje raka) pod nadzorom liječnika koji je kvalificiran za davanje kemoterapije.
Docetaxel Zentiva is used with cisplatin and fluorouracil. 
Docetaxel Zentiva primjenjuje se u kombinaciji s cisplatinom i fluorouracilom.
Why is Docetaxel Zentiva authorised in the EU? 
Zašto je lijek Docetaxel Zentiva odobren u EU-u?
What are the risks associated with Docetaxel Zentiva? 
Koji su rizici povezani s lijekom Docetaxel Zentiva?
It can also be used with cisplatin (another cancer medicine) in patients who have not yet received any treatment for their cancer; 
Može se primjenjivati i u kombinaciji s cisplatinom (drugim lijekom protiv raka) u bolesnika koji nisu još primili nikakvu terapiju za liječenje raka od kojeg boluju;
• non-small cell lung cancer. 
• raka pluća nemalih stanica.
For the full list of restrictions, see the package leaflet. 
Potpuni popis ograničenja povezanih s primjenom potražite u uputi o lijeku.
The active substance in Docetaxel Zentiva, docetaxel, belongs to the group of cancer medicines known as taxanes. 
Djelatna tvar u lijeku Docetaxel Zentiva, docetaksel, pripada taksanima, skupini lijekova protiv raka.
For the full list of side effects with Docetaxel Zentiva, see the package leaflet. 
Potpuni popis nuspojava povezanih s lijekom Docetaxel Zentiva potražite u uputi o lijeku.
Docetaxel Zentiva contains the active substance docetaxel. 
Lijek Docetaxel Zentiva sadrži djelatnu tvar docetaksel.
How does Docetaxel Zentiva work? 
Kako djeluje Docetaxel Zentiva?
What benefits of Docetaxel Zentiva have been shown in studies? 
Koje su koristi od lijeka Docetaxel Zentiva utvrđene u ispitivanjima?
When used on its own, Docetaxel Zentiva was at least as effective as and sometimes more effective than the comparator medicines in breast cancer, and more effective than best supportive care (any medicines or treatment to help patients, but not other cancer medicines) in lung cancer. 
Također se pokazao učinkovitijim od najbolje potporne skrbi (svih lijekova ili terapije za pomoć bolesnicima, ali ne drugih lijekova protiv raka) kod raka pluća.
FI-02200 Espoo FINLAND 
FI-02200 Espoo FINSKA
The volume of one drop is approximately 27 µl. 
Volumen jedne kapi iznosi približno 27 µl.
It is recommended to record the time of first administration. 
Preporučuje se zabilježiti vrijeme prve primjene.
Ropinirole is rapidly distributed and has a relatively high apparent volume of distribution. 
Ropinirol se vrlo brzo distribuira i ima relativno visok očiti volumen distribucije.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 13/04/2018 
Datum prvog odobrenja: 13/04/2018
The fraction bound to plasma proteins in dogs is low (37%). 
Dio koji se veže uz proteine u plazmi pasa je nizak (37 %).
REPEATED DOSE: 
PONOVLJENA DOZA:
Three dogs (3%) did not vomit at all despite an additional dose. 
Tri psa (3 %) nisu uopće povratila ni unatoč dodatnoj dozi.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains: 
KVALITATIVNI I KVANTITATIVNI SASTAV Svaki ml otopine sadrži:
OPENING THE CONTAINER: 
OTVARANJE SPREMNIKA:
Inform your veterinarian if your dog is given other medicines. 
Obavijestite svog veterinara ako pas dobiva druge VMP.
See the detailed instructions for administration at the end of this leaflet. 
Detaljne upute o primjeni potražite pri kraju ove upute.
Pharmacotherapeutic group: Dopaminergic agents, dopamine agonists ATC vet code: QN04BC04 
FARMAKOLOŠKA SVOJSTVA Farmakoterapijska grupa: dopaminergički agensi, agonisti dopamina ATCvet kod: QN04BC04
The portion recovered as unchanged ropinirole in the urine is below 3% within the first 24 hours. 
Dio nepromijenjenog ropinirola u urinu manji je od 3 % tijekom prva 24 sata.
Each eye drop contains 810 µg of ropinirole. 
Svaka kapljica za oko sadrži 810 µg ropinirola.
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/). 
Detaljne informacije o ovom veterinarsko-medicinskom proizvodu dostupne su na web stranici Europske agencije za lijekove (http://www.ema.europa.eu/).
Vomiting starts before the Cmax in plasma is reached; at 4-6 minutes in a pharmacokinetic study in dogs. 
Povraćanje počinje prije nego što se postigne Cmax u plazmi; nakon 4-6 minuta u farmakokinetičkim ispitivanjima na psima.
People with known hypersensitivity to ropinirole should avoid contact with the veterinary medicinal product. 
Osobe s poznatom preosjetljivošću na ropinirol trebaju izbjegavati kontakt s veterinarsko-medicinskim proizvodom.
If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinarian. 
Ako zamijetite bilo koju nuspojavu, čak i one koje nisu navedene u ovoj uputi o VMP ili mislite da veterinarsko-medicinski proizvod ne djeluje, molimo obavijestite svog veterinara.
A very small proportion of dogs may fail to respond to the treatment despite administration of a second dose. 
Vrlo mali broj pasa možda neće odgovoriti na liječenje unatoč primjeni druge doze.